NOT KNOWN FACTUAL STATEMENTS ABOUT CONOLIDINE

These outcomes, together with a preceding report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,two support the principle of focusing on ACKR3 as a unique solution to modulate the opioid method, which could open new therapeutic avenues for opioid-connected Diseases.Take note: Results might differ a